Domestic SUPPLY Act of 2025

Bill: 119-hr-675
Sponsor: full_name: Rep. Griffith, H. Morgan [R-VA-9]
Introduced: 2025-01-23
Policy area: Health
Subjects: Buy American requirements

Cardiovascular and respiratory health

Congressional oversight

Emergency medical services and trauma care

Health personnel

Health promotion and preventive care

Health technology, devices, supplies

Infectious and parasitic diseases

Manufacturing

Product safety and quality

Public contracts and procurement

Public-private cooperation

State and local government operations

Worker safety and health
Latest action: action_date: 2025-01-23
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:
action_date: 2025-01-23
action_desc: Introduced in House
text: <p><strong>Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 or the Domestic SUPPLY Act of 2025</strong></p><p>This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) to address&nbsp;infectious diseases and other public health emergencies.</p><p>Specifically, the Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements with eligible domestic manufacturers for PPE&nbsp;to prepare for and respond to public health emergencies. To be eligible, manufacturers must be majority owned and operated&nbsp;by U.S. citizens and must manufacture a majority of their contracted products domestically, with 100% of products manufactured domestically by 2028. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program.</p><p>In addition, the federal government must only procure, subject to limited exceptions, clothing or equipment that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure such items&nbsp;domestically.</p><p>Further, the bill requires HHS to submit to Congress a report about changes to federal requirements for PPE since&nbsp;the beginning of the&nbsp;COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 675 IN THE HOUSE OF REPRESENTATIVES January 23, 2025 Mr. Griffith introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Oversight and Government Reform , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To direct the Secretary of Health and Human Services, in collaboration with the Assistant Secretary for Preparedness and Response and the Director of the Centers for Disease Control and Prevention, and in coordination with the Secretary of Defense and the Secretary of Homeland Security, to establish a program of entering into partnerships with eligible domestic manufacturers to ensure the availability of qualified personal protective equipment to prepare for and respond to national health or other emergencies, and for other purposes.

1. Short title This Act may be cited as the Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 or the Domestic SUPPLY Act of 2025 . 2. National defense and health security domestic manufacturing partnership program (a) In general The Secretary, in collaboration with the Assistant Secretary for Preparedness and Response and the Director of the Centers for Disease Control and Prevention, and in coordination with the Secretary of Defense and the Secretary of Homeland Security, shall establish a program of entering into partnerships with eligible domestic manufacturers to ensure the availability of qualified personal protective equipment for preparing for, and responding to, public health emergencies. (b) Contractual purchasing agreements (1) Process Not later than 1 year after the date of enactment of this Act, the Secretary shall finalize a process for entering into contractual purchasing agreements with eligible domestic manufacturers to implement the partnerships described in subsection (a). (2) Contents The contractual purchasing agreements entered into under this section, collectively, shall— (A) guarantee the availability of supplies and manufacturing lines to produce qualified personal protective equipment in amounts specified by the Secretary to prepare for and respond to public health emergencies; and (B) fulfill such other requirements as are— (i) deemed necessary by the Secretary to prepare for and respond to a public health emergency; and (ii) covered under the contractual purchasing agreement. (c) Eligible domestic manufacturers To be eligible to participate in a partnership described in subsection (a), a manufacturer shall— (1) be headquartered in the continental United States; (2) manufacture in the continental United States 50 percent of their of the products in 2026, 75 percent of their products by 2027, and 100 percent of their products by 2028 to be supplied to the Federal Government pursuant to such partnership; (3) be majority owned and operated by United States citizens; (4) have supply agreements in place to verify supply chain security and sourcing; and (5) attest in writing to the fact that the manufacturer’s entire product lines meet or exceed all applicable quality guidelines of the Centers for Disease Control and Prevention and the Occupational Safety and Health Administration. (d) Qualified personal protective equipment (1) In general The Secretary shall maintain a list of products that are eligible for treatment as qualified personal protective equipment under this section. (2) Requirements To be included on the list under paragraph (1), a product shall— (A) meet or exceed all applicable quality guidelines of the Centers for Disease Control and Prevention and the Occupational Safety and Health Administration; (B) have been cleared under section 510(k) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360(k) ); and (C) be priced using fair-market benchmarks established by the Secretary. (e) Definitions In this section: (1) The term public health emergency means a public health emergency for which a declaration is in effect under section 319 of the Public Health Service Act ( 42 U.S.C. 247d ). (2) The term Secretary means the Secretary of Health and Human Services. 3. Domestic procurement of clothing or equipment used to prevent the transmission of infectious disease (a) In general No agency of the Federal government or of a State or local government may use Federal funds made available on or after the date of the enactment of this Act to procure clothing or equipment used to prevent the transmission of infectious disease that is manufactured outside the United States. (b) Exceptions The exceptions in subparagraphs (A) and (B) of subsection (a)(2) of section 8302 of title 41, United States Code, shall apply with respect to the prohibition in paragraph (1) of this subsection to the same extent and in the same manner as such exceptions apply with respect to the prohibition in subsection (a)(1) of such section 8302. (c) Exception documentation In the case of an exception described in subsection (b), documentation, including a detailed justification for the use of the exception, shall be submitted by the official responsible for applying the exception. 4. Report on the impact of changes to PPE requirements on frontline worker safety Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Assistant Secretary of Labor for Occupational Safety and Health, shall submit a report to the Congress on— (1) the changes to the Federal requirements applicable to personal protective equipment that have taken place since the beginning of the COVID–19 pandemic; and (2) the impact of these changes on the safety of physicians and other medical professionals caring for patients face-to-face during the years 2020 and 2021.